<DOC>
	<DOC>NCT01004952</DOC>
	<brief_summary>The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk factor for melanoma. The investigators would like to understand the decisions people make about sun protection so that they can improve their ability to help individuals who may be at risk for melanoma.</brief_summary>
	<brief_title>Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection</brief_title>
	<detailed_description />
	<mesh_term>Sunscreening Agents</mesh_term>
	<criteria>A firstdegree biological relative (a child, sibling or parent) as per self report of an MSKCC followup surgical patient diagnosed with melanoma as per pathology report or clinician's judgment; Englishfluent; the surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys. 18 years of age or older; For Phase I only: FDRs who live within a 50 mile radius of MSKCC to make it feasible for Ms. Shuk to be able to arrive at each person's home for the inhome interview without the cost being prohibitive; For Phase I only: Can recall a period when s/he was out in the sun for at least one hour on a sunny day this past summer 2009. For Phase I only: Can recall a separate period when s/he was out in the sun for at least one hour on a sunny day this past summer 2009, but s/he was in a different location from the period referenced above. For Phase II only: FDRs who selfreport at least 1 consecutive hour in the morning (dawn to 12:30pm) and 1 consecutive hour in the afternoon (12:305pm) of daily (weekend and weekday) outdoor activities on the screening questionnaire Firstdegree relatives of melanoma patients who report never using UVR protection; Patient's who provide consent for Phase I will not be eligible for Phase II. Any firstdegree relative of a melanoma patient who already has a firstdegree relative who consented to the study; Unable to provide informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Skin</keyword>
	<keyword>Sunscreen</keyword>
	<keyword>UVR Protection</keyword>
	<keyword>09-137</keyword>
</DOC>